|Incidence of pneumonitis with use of programmed death 1 and programmed death-ligand 1 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis of trials|
M Khunger, S Rakshit, V Pasupuleti, AV Hernandez, P Mazzone, ...
Chest 152 (2), 271-281, 2017
|Perinodular and intranodular radiomic features on lung CT images distinguish adenocarcinomas from granulomas|
N Beig, M Khorrami, M Alilou, P Prasanna, N Braman, M Orooji, S Rakshit, ...
Radiology 290 (3), 783-792, 2019
|Programmed cell death 1 (PD-1) ligand (PD-L1) expression in solid tumors as a predictive biomarker of benefit from PD-1/PD-L1 axis inhibitors: a systematic review and meta-analysis|
M Khunger, AV Hernandez, V Pasupuleti, S Rakshit, NA Pennell, ...
JCO Precision Oncology 1, 1-15, 2017
|Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients|
M Khunger, PD Patil, A Khunger, M Li, B Hu, S Rakshit, A Basu, N Pennell, ...
PloS one 13 (10), e0197743, 2018
|Safety and efficacy of PD-1/PD-L1 inhibitors in treatment-naive and chemotherapy-refractory patients with non–small-cell lung cancer: a systematic review and meta-analysis|
M Khunger, P Jain, S Rakshit, V Pasupuleti, AV Hernandez, J Stevenson, ...
Clinical lung cancer 19 (3), e335-e348, 2018
|Ipilimumab-induced colitis in patients with metastatic melanoma|
KM De Felice, A Gupta, S Rakshit, S Khanna, LA Kottschade, HD Finnes, ...
Melanoma research 25 (4), 321-327, 2015
|An integrated segmentation and shape‐based classification scheme for distinguishing adenocarcinomas from granulomas on lung CT|
M Alilou, N Beig, M Orooji, P Rajiah, V Velcheti, S Rakshit, N Reddy, ...
Medical physics 44 (7), 3556-3569, 2017
|Extramedullary disease in multiple myeloma|
R Bansal, S Rakshit, S Kumar
Blood cancer journal 11 (9), 161, 2021
|Quantitative vessel tortuosity: A potential CT imaging biomarker for distinguishing lung granulomas from adenocarcinomas|
M Alilou, M Orooji, N Beig, P Prasanna, P Rajiah, C Donatelli, V Velcheti, ...
Scientific reports 8 (1), 15290, 2018
|Combination of computer extracted shape and texture features enables discrimination of granulomas from adenocarcinoma on chest computed tomography|
M Orooji, M Alilou, S Rakshit, N Beig, MH Khorrami, P Rajiah, R Thawani, ...
Journal of Medical Imaging 5 (2), 024501-024501, 2018
|Incidence of pneumonitis with use of PD-1 and PD-L1 inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of trials.|
M Khunger, V Pasupuleti, S Rakshit, P Jain, PJ Mazzone, J Stevenson, ...
Journal of Clinical Oncology 35 (15_suppl), e20647-e20647, 2017
|Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology|
JM Dolezal, A Srisuwananukorn, D Karpeyev, S Ramesh, S Kochanny, ...
Nature communications 13 (1), 6572, 2022
|Neutrophil to lymphocyte ratio as a prognostic marker in metastatic gallbladder cancer|
M Mady, K Prasai, SH Tella, S Yadav, CL Hallemeier, S Rakshit, ...
HPB 22 (10), 1490-1495, 2020
|Premature clinical trial discontinuation in the era of immune checkpoint inhibitors|
M Khunger, S Rakshit, AV Hernandez, V Pasupuleti, K Glass, MD Galsky, ...
The Oncologist 23 (12), 1494-1499, 2018
|Immunotherapy in patients with autoimmune disease|
S Rakshit, JR Molina
Journal of Thoracic Disease 12 (11), 7032, 2020
|Meta-analysis of tumor PD-L1 expression as a predictive biomarker of benefit from PD-1/PD-L1 axis inhibitors in solid tumors.|
M Khunger, S Rakshit, KA Schalper, P Elson, NA Pennell, J Stevenson, ...
Journal of Clinical Oncology 34 (15_suppl), 11603-11603, 2016
|Pre-treatment hematological markers as a predictive biomarker for survival in patients with non-small cell lung cancer treated with nivolumab.|
PD Patil, M Khunger, S Rakshit, J Stevenson, NA Pennell, P Elson, ...
Journal of Clinical Oncology 35 (15_suppl), 11547-11547, 2017
|Durable response to combination of dabrafenib and trametinib in BRAF V600E-mutated non–small-cell lung cancer|
LM Pervere, S Rakshit, AB Schrock, VA Miller, SM Ali, V Velcheti
Clinical Lung Cancer 18 (3), e211-e213, 2017
|Computerized textural analysis of lung CT to enable quantification of tumor infiltrating lymphocytes in NSCLC.|
M Orooji, S Rakshit, N Beig, A Madabhushi, V Velcheti
Journal of Clinical Oncology 34 (15_suppl), 11584-11584, 2016
|Outcomes of COVID-19 in patients with cancer: a closer look at pre-emptive routine screening strategies|
Z Xie, AN Saliba, J Abeykoon, U Majeed, DR Almquist, ...
JCO Oncology Practice 17 (9), e1382-e1393, 2021